NCT01294215View on ClinicalTrials.gov

High Dose BAYA1040_Nifedipine: a Long Term Combination Study

PHASE3CompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

June 30, 2012

Conditions

Hypertension

Interventions

DRUG

Nifedipine (Adalat, BAYA1040)

Nifedipine (Adalat, BAYA1040) 40mg twice a day (BID)

Trial Locations (4)

243-0401

Ebina

252-0311

Sagamihara

332-0012

Kawaguchi

169-0072

Shinjuku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY